
Resilience
North America, California, United States, La Jolla
Description
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.
Investor Profile
Resilience has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Seed (50%)
- Series A (25%)
- Series B (25%)
Country Focus
- United States (75%)
- United Kingdom (25%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Therapeutics
- Commercial
- B2b
- Food Processing
- Iaas
- Marketplace
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.